Healthcare

12:01

                            Hong Kong Stocks Midday Review: Hang Seng Index fell 0.12% Hang Seng Technology Index rose 0.15%
                        
                            At the close of Hong Kong stocks at noon, the Hang Seng Index fell 0.12%, and the Hang Seng Technology Index rose 0.15%. Oil and gas stocks and domestic real estate stocks led the gains, with Shandong Molong rising more than 30%, ZhongAn Online and R&F Properties rising nearly 10%, and WuXi Biologics falling more than 6%.
                        
09:23

                            Hong Kong stocks opened, the Hang Seng Index opened down 0.42%, the Sci-Tech Index opened down 0.61%. WuXi Biologics (02269.HK) fell 3.57% as the company's major shareholder placed existing shares.
                        
07:35

                            WuXi Biologics: Major shareholder places existing shares
                        
                            WuXi Biologics announced on the Hong Kong Stock Exchange that on June 14, the company's board of directors was informed by one of the company's major shareholders that it had entered into a block transaction agreement with Morgan Stanley International plc, pursuant to which the placing agent has agreed to place 82.94 million existing shares of the company held by Biologics Holdings (equivalent to approximately 2.04% of the total issued share capital of the Company as of the date of this announcement) to parties independent of and not related to the Company at a price of HK$26.6 per share.
                        
16:07

                            Market news: Novo Nordisk (NVO.N) surpasses SAP SE (SAP.N) to become Europe's most valuable company.
                        
21:49

                            BeiGene's US stocks rose nearly 7%
                        
                            BeiGene's U.S. stocks rose nearly 7%. The FDA's official website showed that BeiGene's Zebutinib tablets were approved for marketing.
                        
16:52

                            Eli Lilly's multi-dose prefilled pen for telportolide injection is launched in China
                        
                            Eli Lilly announced that on June 12, 2025, Mufengda (multi-dose prefilled pen for telportolide injection) was launched in China. This is a new injection device launched by Eli Lilly after the successful launch of telportolide at the beginning of the year to increase supply in China and meet the needs of more patients.
                        
14:46

                            The concept of innovative drugs in A-shares continued to be active. Hisun Pharmaceuticals hit the daily limit in the late trading, Osaikang hit the daily limit before that, Shutaishen and Ruizhi Pharmaceutical rose by more than 10%, Qianhong Pharmaceutical, BeiGene, and Changchun High-Tech rose by more than 5%.
                        
14:44

                            Innovative drug concepts continue to be active; Hisun Pharmaceutical and Aosaikang hit their daily limit
                        
                            The concept of innovative drugs continued to be active, with Hisun and Osaikang hitting their daily limit, Shutaishen and Ruizhi Pharmaceutical rising by more than 10%, Qianhong Pharmaceutical, BeiGene, and Changchun High-Tech rising by more than 5%.
                        
13:20

                            Hong Kong-listed biopharmaceutical stocks strengthened again in the afternoon, with Rongchang Biopharma (09995.HK) rising more than 20%, Zai Lab (09688.HK) rising more than 10%, Junshi Biosciences (01877.HK) and BeiGene (06160.HK) rising more than 7%, Kelun Biotech (06990.HK) rising more than 6.5%, and WuXi AppTec (02359.HK) rising more than 5%.
                        
13:16

                            Hong Kong stocks of innovative drugs strengthened in the afternoon, Rongchang Biopharma and China Biopharmaceutical rose by more than 15%
                        
                            Hong Kong stocks with innovative drug concepts strengthened in the afternoon, with Rongchang Biopharma and China Biologic Products rising by more than 15%, Junshi Biosciences, Zhaoyan Pharmaceutical, BeiGene, and CStone Pharmaceuticals rising by more than 5%.
                        
09:55

                            Hong Kong-listed biopharmaceutical stocks rose in early trading, with Zai Lab (09688.HK) up more than 8.5%, Kelun Biotech (06990.HK) up nearly 6%, BeiGene (06160.HK) up more than 4%, Rongchang Biopharmaceuticals (09995.HK), WuXi Biologics (02269.HK), InnoCare Pharma (09969.HK), and WuXi AppTec (02359.HK) all up more than 3%.
                        
18:55

                            Nvidia collaborates with Novo Nordisk and the Danish Center for Artificial Intelligence Innovation (DCAI) to advance drug discovery
                        
                            Nvidia is collaborating with Novo Nordisk and the Danish Center for Artificial Intelligence Innovation (DCAI) to advance drug discovery.
                        
16:02

                            Novo Nordisk's US stock rose more than 2% before the market opened
                        
                            Novo Nordisk's U.S. shares rose more than 2% in pre-market trading after media reports that Parvus Asset Management was increasing its stake in Novo Nordisk.
                        
09:46

                            Hong Kong-listed pharmaceutical stocks fluctuated upward; Tigermed rose more than 7%
                        
                            Hong Kong-listed pharmaceutical stocks fluctuated upward, with Tiger Pharmaceuticals rising more than 7%, CStone Pharmaceuticals and Corning Life Sciences both rising nearly 6%, Zhaoyan Pharmaceutical rising more than 5.5%, and WuXi Biologics rising more than 4%.
                        
10:07

                            Hong Kong-listed biopharmaceutical stocks fluctuated and rose during the session; GenScript Biopharma rose more than 10%
                        
                            Hong Kong-listed biopharmaceutical stocks fluctuated upward during intraday trading, with GeneScript Biopharma rising more than 10%, InnoCare Pharma rising more than 9%, Tiger Pharmaceuticals rising more than 6%, Junshi Biosciences rising more than 5%, and WuXi Biologics rising more than 4%.
                        
1750046484
119325
3

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Trends

AI AI Tesla bitcoin Nvidia Xiaomi Apple Alibaba Tencent Huawei

Weekly Highlights

                                    Arm (ARM.O): We are better than Nvidia on a wider range of platforms.
                            2025-06-12

                                    Lei Jun: Xiaomi Yu7 will be released at the end of June
                            2025-06-16

                                    Putin: Russia will create unmanned system forces as a separate branch of the military
                            2025-06-13

                                    Barclays: Raised Oracle (ORCL.N) price target from $202 to $221.
                            2025-06-13

                                    Economic Daily: Let artificial intelligence run at Chinese speed
                            2025-06-13